drugset / Trial / NCT00004166

Amifostine in Treating Patients With Ovarian Epithelial Cancer Who Are Receiving Chemotherapy

NCT00004166

RandomizedSupportive care

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Chemoprotective drugs such as amifostine may protect normal cells from the side effects of chemotherapy. PURPOSE: Randomized phase III trial to study the effectiveness of amifostine in treating patients who have ovarian epithelial cancer and who are receiving chemotherapy.

Timeline

Start
1999-10
Primary completion
2003-01
Completion
2003-01

Drugs

EvaluationDrugModalityDoseRoute
Subject amifostine Unknown Intravenous

Indications